[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100220916":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":11,"locations":24,"responsibleParty":45,"collaborators":11,"id":49,"slug":11,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":57,"maxAge":11,"enrollmentInfo":58,"targetDuration":11,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":11,"overallStatus":27,"whyStopped":11,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Implantable loop recorders Reveal ICM LINQ®,","EXPERIMENTAL",null,[13],"Device: Implantable loop recorders system Reveal ICM LINQ®,",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":11},"DEVICE","Implantable loop recorders system Reveal ICM LINQ®,",[9],[20],{"name":21,"affiliation":22,"role":23},"Josep Rodes, MD","Fondation IUCPQ","PRINCIPAL_INVESTIGATOR",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"IUCPQ","RECRUITING","Québec","Quebec","G1V 4G5","Canada",{"type":33,"coordinates":34},"Point",[35,36],-71.21454,46.81228,{"lat":36,"lon":35},[39],{"name":40,"role":41,"phone":42,"phoneExt":43,"email":44},"Emilie Pelletier Beaumont, M.Sc.","CONTACT","418-656-8711","3929","Emilie.Pelletier-Beaumont@criucpq.ulaval.ca",{"type":23,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":48,"oldNameTitle":11,"oldOrganization":11},"Josep Rodes-Cabau","MD","Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","100220916",false,"NCT02153307","Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The \"MARE\" Study","MARE","Inclusion Criteria:\n\n-Patients undergoing TAVI with either balloon or self-expandable valves who develop new-onset LBBB persistent at hospital discharge, at least 3 days after the procedure\n\nExclusion Criteria:\n\n* Failure to provide informed consent\n* Baseline pacemaker\u002Fdefibrillator or pacemaker\u002Fdefibrillator implanted during the hospitalization period following the TAVI procedure\n* Pre-existing complete LBBB\n* Patients with a life-expectancy of less than 2 years",true,"ALL","18 Years",{"count":59,"type":60},80,"ESTIMATED","INTERVENTIONAL",[63],"NA","The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve implantation (TAVI) and to evaluate the usefulness of the Reveal LINQ® insertable Cardiac Monitor (ICM) (Medtronic, Inc., Minneapolis, USA) for the detection of significant arrhythmias in patients with NOP-LBBB following TAVI.",[66,67],"Aortic Valve Disease","Conduction Disturbances","2026-03-23",{"date":70,"type":71},"2026-03-24","ACTUAL",{"date":73,"type":11},"2014-01",{"date":75,"type":60},"2026-07",{"name":48,"class":6},1]